The hidden risks of over-reliance on healthy donor material
Drug Target Review
OCTOBER 10, 2024
In the context of preclinical research, using healthy cells to study disease-specific mechanisms, cell-cell interactions, and immune responses can result in faulty data, missed therapeutic targets, and unanticipated immune responses. Healthy cells may also serve as a valuable control in experiments.
52 
Let's personalize your content